当前位置: X-MOL 学术J. Am. Coll. Cardiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Improving Outcome in Patients With Tricuspid Regurgitation: Look At the Kidneys and the Liver!
Journal of the American College of Cardiology ( IF 21.7 ) Pub Date : 2024-12-09 , DOI: 10.1016/j.jacc.2024.09.1238
Marco Metra MD, Marianna Adamo MD PhD, Javed Butler MD MPH MBA

Section snippets

Funding Support and Author Disclosures

Dr Metra has received consulting fees from Abbott Structural Heart, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Edwards Lifesciences, and Novo Nordisk. Dr Adamo has received consultant/speaker honoraria from Abbott Vascular and Edwards Lifesciences. Dr Butlar is a consultant for Abbott, American Regent, Amgen, Applied Therapeutic, AskBio, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardiac Dimension, Cardiocell, Cardior, CSL Bearing,


中文翻译:


改善三尖瓣反流患者的预后:看看肾脏和肝脏!


 部分片段


资金支持和作者披露


Metra 博士已收到 Abbott Structural Heart、阿斯利康、拜耳、勃林格殷格翰、Cytokinetics、Edwards Lifesciences 和 Novo Nordisk 的咨询费。Adamo 博士获得了 Abbott Vascular 和 Edwards Lifesciences 的顾问/演讲者酬金。Butlar 博士是雅培、美国摄政、安进、Applied Therapeutic、AskBio、安斯泰来、阿斯利康、拜耳、勃林格殷格翰、波士顿科学、百时美施贵宝、Cardiac Dimension、Cardiocell、Cardior、CSL Bearing 的顾问。
更新日期:2024-12-09
down
wechat
bug